ID   CGAT1_HUMAN             Reviewed;         532 AA.
AC   Q8TDX6; B2RBE4; Q6P9G6; Q8IUF9; Q9NSQ7; Q9NUM9;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   10-MAY-2017, entry version 132.
DE   RecName: Full=Chondroitin sulfate N-acetylgalactosaminyltransferase 1 {ECO:0000305};
DE            Short=CsGalNAcT-1 {ECO:0000305};
DE            EC=2.4.1.174 {ECO:0000269|PubMed:21160489, ECO:0000269|PubMed:27599773};
DE   AltName: Full=Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1;
DE            Short=Beta4GalNAcT-1;
GN   Name=CSGALNACT1 {ECO:0000312|HGNC:HGNC:24290};
GN   Synonyms=CHGN, GALNACT1; ORFNames=UNQ656/PRO1287;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, GLYCOSYLATION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANT ASN-193.
RC   TISSUE=Melanoma;
RX   PubMed=11788602; DOI=10.1074/jbc.M111434200;
RA   Uyama T., Kitagawa H., Tamura J., Sugahara K.;
RT   "Molecular cloning and expression of human chondroitin N-
RT   acetylgalactosaminyltransferase: key enzyme for chain initiation and
RT   elongation of chondroitin/dermatan sulfate on the protein linkage
RT   region tetrasaccharide shared by heparin/heparan sulfate.";
RL   J. Biol. Chem. 277:8841-8846(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND VARIANT ASN-193.
RX   PubMed=12163485; DOI=10.1074/jbc.M203619200;
RA   Gotoh M., Sato T., Akashima T., Iwasaki H., Kameyama A., Mochizuki H.,
RA   Yada T., Inaba N., Zhang Y., Kikuchi N., Kwon Y.-D., Togayachi A.,
RA   Kudo T., Nishihara S., Watanabe H., Kimata K., Narimatsu H.;
RT   "Enzymatic synthesis of chondroitin with a novel chondroitin sulfate
RT   N-acetylgalactosaminyltransferase that transfers N-acetylgalactosamine
RT   to glucuronic acid in initiation and elongation of chondroitin sulfate
RT   synthesis.";
RL   J. Biol. Chem. 277:38189-38196(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASN-193.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ASN-193.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 381-532, AND VARIANT
RP   ASN-193.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12446672; DOI=10.1074/jbc.M208886200;
RA   Sato T., Gotoh M., Kiyohara K., Akashima T., Iwasaki H., Kameyama A.,
RA   Mochizuki H., Yada T., Inaba N., Togayachi A., Kudo T., Asada M.,
RA   Watanabe H., Imamura T., Kimata K., Narimatsu H.;
RT   "Differential roles of two N-acetylgalactosaminyltransferases,
RT   CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2. Initiation and
RT   elongation in synthesis of chondroitin sulfate.";
RL   J. Biol. Chem. 278:3063-3071(2003).
RN   [9]
RP   FUNCTION.
RX   PubMed=17145758; DOI=10.1074/jbc.M606870200;
RA   Sakai K., Kimata K., Sato T., Gotoh M., Narimatsu H., Shinomiya K.,
RA   Watanabe H.;
RT   "Chondroitin sulfate N-acetylgalactosaminyltransferase-1 plays a
RT   critical role in chondroitin sulfate synthesis in cartilage.";
RL   J. Biol. Chem. 282:4152-4161(2007).
RN   [10]
RP   VARIANTS ARG-234 AND ARG-509, CHARACTERIZATION OF VARIANTS ARG-234 AND
RP   ARG-509, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=21160489; DOI=10.1038/jhg.2010.148;
RA   Saigoh K., Izumikawa T., Koike T., Shimizu J., Kitagawa H.,
RA   Kusunoki S.;
RT   "Chondroitin beta-1,4-N-acetylgalactosaminyltransferase-1 missense
RT   mutations are associated with neuropathies.";
RL   J. Hum. Genet. 56:143-146(2011).
RN   [11]
RP   INVOLVEMENT IN DISEASE, VARIANT ARG-384, CHARACTERIZATION OF VARIANT
RP   ARG-384, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27599773; DOI=10.1002/humu.23070;
RA   Vodopiutz J., Mizumoto S., Lausch E., Rossi A., Unger S., Janocha N.,
RA   Costantini R., Seidl R., Greber-Platzer S., Yamada S., Mueller T.,
RA   Jilma B., Ganger R., Superti-Furga A., Ikegawa S., Sugahara K.,
RA   Janecke A.R.;
RT   "Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1)
RT   Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity.";
RL   Hum. Mutat. 38:34-38(2017).
CC   -!- FUNCTION: Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-
CC       GalNAc to the non-reducing end of glucuronic acid (GlcUA).
CC       Required for addition of the first GalNAc to the core
CC       tetrasaccharide linker and for elongation of chondroitin chains.
CC       Important role in chondroitin chain biosynthesis in cartilage
CC       formation and subsequent endochondral ossification
CC       (PubMed:11788602, PubMed:12163485, PubMed:12446672,
CC       PubMed:17145758). Moreover, is involved in the metabolism of
CC       aggrecan (By similarity). {ECO:0000250|UniProtKB:Q8BJQ9,
CC       ECO:0000269|PubMed:11788602, ECO:0000269|PubMed:12163485,
CC       ECO:0000269|PubMed:12446672, ECO:0000269|PubMed:17145758,
CC       ECO:0000269|PubMed:21160489, ECO:0000269|PubMed:27599773}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-D-galactosamine + beta-D-
CC       glucuronyl-(1->3)-D-galactosyl-proteoglycan = UDP + N-acetyl-D-
CC       galactosaminyl-(1->4)-beta-D-glucuronyl-(1->3)-beta-D-
CC       galactosylproteoglycan. {ECO:0000269|PubMed:21160489,
CC       ECO:0000269|PubMed:27599773}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane
CC       {ECO:0000305|PubMed:11788602}; Single-pass type II membrane
CC       protein {ECO:0000305|PubMed:11788602}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TDX6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDX6-2; Sequence=VSP_012726, VSP_012727;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8TDX6-3; Sequence=VSP_012728;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with the highest levels in
CC       placenta, thyroid, bladder, prostate and adrenal gland. Detected
CC       at low levels in the other tissues examined.
CC       {ECO:0000269|PubMed:11788602, ECO:0000269|PubMed:12163485,
CC       ECO:0000269|PubMed:12446672}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11788602}.
CC   -!- SIMILARITY: Belongs to the chondroitin N-
CC       acetylgalactosaminyltransferase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_477";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB071403; BAB85992.1; -; mRNA.
DR   EMBL; AB081516; BAC16217.1; -; mRNA.
DR   EMBL; AY358441; AAQ88806.1; -; mRNA.
DR   EMBL; AK002126; BAA92093.1; -; mRNA.
DR   EMBL; AK314625; BAG37191.1; -; mRNA.
DR   EMBL; AC090541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090786; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116376; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC060772; AAH60772.1; -; mRNA.
DR   EMBL; AL157483; CAB75673.1; -; mRNA.
DR   CCDS; CCDS6010.1; -. [Q8TDX6-1]
DR   PIR; T46919; T46919.
DR   RefSeq; NP_001123990.1; NM_001130518.1. [Q8TDX6-1]
DR   RefSeq; NP_060841.5; NM_018371.4. [Q8TDX6-1]
DR   RefSeq; XP_006716421.1; XM_006716358.2. [Q8TDX6-1]
DR   RefSeq; XP_006716422.1; XM_006716359.2. [Q8TDX6-1]
DR   RefSeq; XP_006716423.1; XM_006716360.2. [Q8TDX6-1]
DR   RefSeq; XP_006716424.1; XM_006716361.2. [Q8TDX6-1]
DR   RefSeq; XP_006716425.1; XM_006716362.2. [Q8TDX6-1]
DR   RefSeq; XP_006716426.1; XM_006716363.1. [Q8TDX6-1]
DR   RefSeq; XP_006716427.1; XM_006716364.3. [Q8TDX6-1]
DR   RefSeq; XP_011542880.1; XM_011544578.1. [Q8TDX6-1]
DR   RefSeq; XP_011542881.1; XM_011544579.1. [Q8TDX6-1]
DR   RefSeq; XP_011542882.1; XM_011544580.1. [Q8TDX6-1]
DR   RefSeq; XP_011542884.1; XM_011544582.1. [Q8TDX6-1]
DR   RefSeq; XP_011542885.1; XM_011544583.1. [Q8TDX6-1]
DR   RefSeq; XP_011542886.1; XM_011544584.1. [Q8TDX6-1]
DR   RefSeq; XP_016869112.1; XM_017013623.1. [Q8TDX6-1]
DR   RefSeq; XP_016869113.1; XM_017013624.1. [Q8TDX6-1]
DR   RefSeq; XP_016869114.1; XM_017013625.1. [Q8TDX6-1]
DR   RefSeq; XP_016869115.1; XM_017013626.1. [Q8TDX6-1]
DR   RefSeq; XP_016869116.1; XM_017013627.1. [Q8TDX6-1]
DR   RefSeq; XP_016869117.1; XM_017013628.1. [Q8TDX6-1]
DR   RefSeq; XP_016869118.1; XM_017013629.1. [Q8TDX6-1]
DR   RefSeq; XP_016869119.1; XM_017013630.1. [Q8TDX6-1]
DR   RefSeq; XP_016869120.1; XM_017013631.1. [Q8TDX6-1]
DR   RefSeq; XP_016869121.1; XM_017013632.1. [Q8TDX6-1]
DR   RefSeq; XP_016869122.1; XM_017013633.1. [Q8TDX6-1]
DR   RefSeq; XP_016869123.1; XM_017013634.1. [Q8TDX6-1]
DR   RefSeq; XP_016869124.1; XM_017013635.1. [Q8TDX6-1]
DR   RefSeq; XP_016869125.1; XM_017013636.1. [Q8TDX6-1]
DR   RefSeq; XP_016869126.1; XM_017013637.1. [Q8TDX6-1]
DR   RefSeq; XP_016869127.1; XM_017013638.1. [Q8TDX6-1]
DR   UniGene; Hs.613729; -.
DR   UniGene; Hs.721954; -.
DR   ProteinModelPortal; Q8TDX6; -.
DR   BioGrid; 120904; 13.
DR   IntAct; Q8TDX6; 1.
DR   STRING; 9606.ENSP00000310891; -.
DR   BindingDB; Q8TDX6; -.
DR   ChEMBL; CHEMBL2040705; -.
DR   CAZy; GT7; Glycosyltransferase Family 7.
DR   iPTMnet; Q8TDX6; -.
DR   PhosphoSitePlus; Q8TDX6; -.
DR   BioMuta; CSGALNACT1; -.
DR   DMDM; 308153425; -.
DR   MaxQB; Q8TDX6; -.
DR   PaxDb; Q8TDX6; -.
DR   PeptideAtlas; Q8TDX6; -.
DR   PRIDE; Q8TDX6; -.
DR   Ensembl; ENST00000332246; ENSP00000330805; ENSG00000147408. [Q8TDX6-1]
DR   Ensembl; ENST00000397998; ENSP00000381084; ENSG00000147408. [Q8TDX6-3]
DR   Ensembl; ENST00000454498; ENSP00000411816; ENSG00000147408. [Q8TDX6-1]
DR   Ensembl; ENST00000519222; ENSP00000428216; ENSG00000147408. [Q8TDX6-3]
DR   Ensembl; ENST00000522854; ENSP00000429809; ENSG00000147408. [Q8TDX6-1]
DR   GeneID; 55790; -.
DR   KEGG; hsa:55790; -.
DR   UCSC; uc003wzg.4; human. [Q8TDX6-1]
DR   CTD; 55790; -.
DR   DisGeNET; 55790; -.
DR   GeneCards; CSGALNACT1; -.
DR   H-InvDB; HIX0007349; -.
DR   HGNC; HGNC:24290; CSGALNACT1.
DR   HPA; HPA061336; -.
DR   MIM; 616615; gene.
DR   neXtProt; NX_Q8TDX6; -.
DR   OpenTargets; ENSG00000147408; -.
DR   PharmGKB; PA162382829; -.
DR   eggNOG; KOG3588; Eukaryota.
DR   eggNOG; ENOG410XNYM; LUCA.
DR   GeneTree; ENSGT00760000119143; -.
DR   HOGENOM; HOG000230628; -.
DR   HOVERGEN; HBG050930; -.
DR   InParanoid; Q8TDX6; -.
DR   KO; K00746; -.
DR   OMA; GKEEMNE; -.
DR   OrthoDB; EOG091G070I; -.
DR   PhylomeDB; Q8TDX6; -.
DR   TreeFam; TF318303; -.
DR   BioCyc; MetaCyc:HS07428-MONOMER; -.
DR   BRENDA; 2.4.1.174; 2681.
DR   BRENDA; 2.4.1.175; 2681.
DR   Reactome; R-HSA-2022870; Chondroitin sulfate biosynthesis.
DR   ChiTaRS; CSGALNACT1; human.
DR   GeneWiki; ChGn; -.
DR   GenomeRNAi; 55790; -.
DR   PRO; PR:Q8TDX6; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000147408; -.
DR   CleanEx; HS_CSGALNACT1; -.
DR   ExpressionAtlas; Q8TDX6; baseline and differential.
DR   Genevisible; Q8TDX6; HS.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030173; C:integral component of Golgi membrane; NAS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IC:UniProtKB.
DR   GO; GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0047238; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0047237; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; NAS:UniProtKB.
DR   GO; GO:0008955; F:peptidoglycan glycosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; NAS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0008037; P:cell recognition; NAS:UniProtKB.
DR   GO; GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0050653; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0050651; P:dermatan sulfate proteoglycan biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; NAS:UniProtKB.
DR   GO; GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0030210; P:heparin biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0030166; P:proteoglycan biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0046398; P:UDP-glucuronate metabolic process; IDA:UniProtKB.
DR   GO; GO:0019276; P:UDP-N-acetylgalactosamine metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR008428; Chond_GalNAc.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF05679; CHGN; 1.
DR   SUPFAM; SSF53448; SSF53448; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Disease mutation; Glycoprotein; Golgi apparatus; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    532       Chondroitin sulfate N-
FT                                acetylgalactosaminyltransferase 1.
FT                                /FTId=PRO_0000189564.
FT   TOPO_DOM      1     14       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     15     35       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     36    532       Lumenal. {ECO:0000255}.
FT   COILED       57    100       {ECO:0000255}.
FT   METAL       360    360       Divalent metal cation. {ECO:0000255}.
FT   METAL       477    477       Divalent metal cation. {ECO:0000255}.
FT   CARBOHYD    315    315       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    324    324       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    257       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012726.
FT   VAR_SEQ     258    282       MANTLINVIVPLAKRVDKFRQFMQN -> MESYSVTQAGVQ
FT                                WHELCSLQPSPPR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012727.
FT   VAR_SEQ     285    532       EMCIEQDGRVHLTVVYFGKEEINEVKGILENTSKAANFRNF
FT                                TFIQLNGEFSRGKGLDVGARFWKGSNVLLFFCDVDIYFTSE
FT                                FLNTCRLNTQPGKKVFYPVLFSQYNPGIIYGHHDAVPPLEQ
FT                                QLVIKKETGFWRDFGFGMTCQYRSDFINIGGFDLDIKGWGG
FT                                EDVHLYRKYLHSNLIVVRTPVRGLFHLWHEKRCMDELTPEQ
FT                                YKMCMQSKAMNEASHGQLGMLVFRHEIEAHLRKQKQKTSSK
FT                                KT -> PADEVFRCVPLSP (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012728.
FT   VARIANT     137    137       V -> I (in dbSNP:rs17128518).
FT                                /FTId=VAR_055647.
FT   VARIANT     193    193       S -> N (in dbSNP:rs7017776).
FT                                {ECO:0000269|PubMed:11788602,
FT                                ECO:0000269|PubMed:12163485,
FT                                ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_060391.
FT   VARIANT     234    234       H -> R (found in a patient with
FT                                neuropathy; unknown pathological
FT                                significance; loss of GalNAc-transferase
FT                                activity; no effect on protein
FT                                expression).
FT                                {ECO:0000269|PubMed:21160489}.
FT                                /FTId=VAR_078123.
FT   VARIANT     384    384       P -> R (probable disease-associated
FT                                mutation found in a patient with a mild
FT                                skeletal dysplasia with shortness of long
FT                                bones of prenatal onset; loss of GalNAc-
FT                                transferase activity).
FT                                {ECO:0000269|PubMed:27599773}.
FT                                /FTId=VAR_078124.
FT   VARIANT     473    473       F -> Y (in dbSNP:rs17128366).
FT                                /FTId=VAR_055648.
FT   VARIANT     509    509       M -> R (found in a patient with
FT                                neuropathy; unknown pathological
FT                                significance; loss of GalNAc-transferase
FT                                activity; no effect on protein
FT                                expression).
FT                                {ECO:0000269|PubMed:21160489}.
FT                                /FTId=VAR_078125.
FT   CONFLICT    246    246       G -> S (in Ref. 1; BAB85992 and 3;
FT                                AAQ88806). {ECO:0000305}.
FT   CONFLICT    252    252       K -> E (in Ref. 6; AAH60772).
FT                                {ECO:0000305}.
FT   CONFLICT    312    312       I -> V (in Ref. 4; BAA92093).
FT                                {ECO:0000305}.
SQ   SEQUENCE   532 AA;  61294 MW;  DB76B0FD6D74FD82 CRC64;
     MMMVRRGLLA WISRVVVLLV LLCCAISVLY MLACTPKGDE EQLALPRANS PTGKEGYQAV
     LQEWEEQHRN YVSSLKRQIA QLKEELQERS EQLRNGQYQA SDAAGLGLDR SPPEKTQADL
     LAFLHSQVDK AEVNAGVKLA TEYAAVPFDS FTLQKVYQLE TGLTRHPEEK PVRKDKRDEL
     VEAIESALET LNSPAENSPN HRPYTASDFI EGIYRTERDK GTLYELTFKG DHKHEFKRLI
     LFRPFGPIMK VKNEKLNMAN TLINVIVPLA KRVDKFRQFM QNFREMCIEQ DGRVHLTVVY
     FGKEEINEVK GILENTSKAA NFRNFTFIQL NGEFSRGKGL DVGARFWKGS NVLLFFCDVD
     IYFTSEFLNT CRLNTQPGKK VFYPVLFSQY NPGIIYGHHD AVPPLEQQLV IKKETGFWRD
     FGFGMTCQYR SDFINIGGFD LDIKGWGGED VHLYRKYLHS NLIVVRTPVR GLFHLWHEKR
     CMDELTPEQY KMCMQSKAMN EASHGQLGML VFRHEIEAHL RKQKQKTSSK KT
//
